Form 8-K Precision Therapeutics For: Apr 04 – StreetInsider.com

By /

Form 8-K Precision Therapeutics For: Apr 04 StreetInsider.com

UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d) of.

About The Author

Scroll to Top